- Researchers evaluated an NMR-based blood test capable of screening dogs for multiple diseases simultaneously.
- The study included 139 dogs from veterinary centers in Italy.
- The platform identified cancer and cardiovascular disease while also assessing overall health.
- Findings were published in Frontiers in Veterinary Science.
A peer-reviewed study published in Frontiers in Veterinary Science describes a new blood-testing approach that combines nuclear magnetic resonance (NMR) metabolomics with machine learning to screen dogs for multiple diseases using a single blood sample.
The study, conducted by researchers from Link University in Rome, the University of Oxford and collaborating veterinary centers, evaluated LatusPet’s SINO platform in 139 dogs. According to the authors, the platform distinguished cancer and cardiovascular disease while providing an overall health assessment, achieving an area under the receiver operating characteristic curve (ROC AUC) exceeding 90%.
Unlike many diagnostic studies that compare affected animals only with healthy controls, the researchers evaluated each disease against a mixed population that included both healthy dogs and dogs with other medical conditions, a design intended to better reflect real-world clinical practice.
“Beyond early detection, there is real potential for non-invasive monitoring of treatment over time,” said lead author Riccardo Finotello, DVM, professor at Link University, who noted the technology may also have future applications for monitoring treatment response and disease remission.
LatusPet said it plans to expand validation studies to larger patient populations, add additional disease targets and extend the platform to other animal species.
Study: https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2026.1830153/full
Information sourced from the company’s press release.
